Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T01:06:10.979Z Has data issue: false hasContentIssue false

In Vivo XRF Measurements of Heavy Elements: Summary of a Workshop

Published online by Cambridge University Press:  06 March 2019

M. Garbauskas
Affiliation:
General Electric
A. L. Hanson
Affiliation:
Brookhaven National Laboratory
M. Kosnet
Affiliation:
University of California at San Francisco
R. W Ryon
Affiliation:
Lawrence Livermore National Laboratory
L. Wielopolski
Affiliation:
Brookhaven National Laboratory
Get access

Extract

This is a brief summary of the first workshop of “In Vivo XRF Measurements of Heavy Elements,” at the Denver Conference on Applications of X-Ray Analysis. In vivo x-ray fluorescence has been applied to medical applications since the 1960's, with much of the pioneering work being done in Sweden (1). First measurements were of iodine in the thyroid. Elements from iron to uranium have now been measured, at natural and elevated levels. Elevated levels occur either unintentionally through occupational or environmental exposure, or intentionally through medical administration. Examples of measurements are cadmium in kidney and liver, platinum in kidneys and tumors, mercury in the wrists and skulls of dentists, lead in various near-surface bones, copper in the eye and iron in skin. Nearly all measurements make use of either silicon or germanium detectors; radioisotopes and less frequently x-ray tubes are used for excitation.

Type
VIII. In Vivo Applications of XRS
Copyright
Copyright © International Centre for Diffraction Data 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Christoffersson, J.O., In Vivo Elemental Analysis in Occupational Medicine using X-Ray Fluorescence,” thesis, Malm-006-o(o, 172), Sweden, 1986.Google Scholar
2. Todd, A.C., McNeill, F.E., Palethorpe, J.E., Peach, D.E., Chettle, D.R., Tobin, M.J., Strosko, SJ, and Rosen, J.C., Environmental Research 57: 117132, 1992.Google Scholar
3. Slatkin, D.N., Kalef-Ezra, J.A., Baibi, K.E., Wielopolski L. and Rosen, J.F., Radiation Protection Dosimetry, 42, 319322 1992.Google Scholar
4. Todd, A.C., Landrigan, PJ. and Block, P., Neurotoxicology 14(1): 145154, 1993.Google Scholar
5. Gerhardsson, L., Chettle, D.R., Englyst, V., Nordberg, G.F., Nyhlin, H., Scott, M.C., Todd, A.C. and Vesterberg, O., Brit J Indust Med, 49, 186192 1992.Google Scholar
6. H, H.Pepper, L. and Goldman, R., Am J Indnst Med, 33, 723735 1991.Google Scholar
7. Kosnett, M.J., Becker, C.E., Osterloh, J.D., Kelly, TJ. and Pasta, D.J., JAMA, 271, 197203 1994.Google Scholar
8. Todd, A.C. and Chettle, D.R., Environmental Health Persp, 102, 172177 1994.Google Scholar
9. Bertin, E.P., Principles and Practise of X-ray Spectrometic Analysis”, 2nd ed., Plenum Press, NY 1975.Google Scholar
10. Cesareo R., Hanson, A.L., Gigante, G.E., Pedraza, L.J. and Mahtaboally, S.Q. G., Phys. Rep., 213, 117 1992.Google Scholar
11. Hanson, A.L., NIM A264, 471-483, 1988.Google Scholar
12. Berger, M.J. and Hubbell, J.H., NIST Report NBSIR 87-3597 1987.Google Scholar
13. Gardner, R.P., Wielopolski, L. and Verghese, K., Atomic Energy Review, 15, 701754 1977.Google Scholar
14. Wielopolski L. and Gardner, R.P., NIM, 140, 297303 1977.Google Scholar
15. Wielopolski L. and Gardner, R.P., NIM, 165, 297306 1979.Google Scholar
16. Pie T., Gardner, R.P. and Verghese, K., NIM Phys. Res. A299, 354366, 1990.Google Scholar
17. Wielopolski, L., NIM, 190, 177180 1981.Google Scholar